ARTICLE | Clinical News
AQS1301: Clinical trial started
January 18, 2017 12:52 AM UTC
Aequus began a Canadian proof-of-concept (POC) trial to evaluate once-weekly transdermal AQS1301 for 4 weeks in 8 healthy male volunteers. Aequus and Corium are partnered to develop AQS1301. Aequus ha...
BCIQ Company Profiles